Eli Lilly launches once-a-week diabetes drug in India

The once-a-week non-insulin injectable Trulicity is distinct in the duration of dosage compared to products like Novo Nordisk's Victoza or Sanofi's Lantus.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news